tiprankstipranks
TScan Therapeutics Reports Q3 2024 Financial Results
PremiumCompany AnnouncementsTScan Therapeutics Reports Q3 2024 Financial Results
2M ago
TScan Therapeutics reports Q3 EPS (25c), consensus (29c)
Premium
The Fly
TScan Therapeutics reports Q3 EPS (25c), consensus (29c)
2M ago
TScan Therapeutics announces preliminary results from ALLOHA Phase 1 trial
Premium
The Fly
TScan Therapeutics announces preliminary results from ALLOHA Phase 1 trial
2M ago
TScan Therapeutics receives FDA’s RMAT designation for two TCR-T candidates
PremiumThe FlyTScan Therapeutics receives FDA’s RMAT designation for two TCR-T candidates
8M ago
TScan Therapeutics initiated with a Buy at BTIG
Premium
The Fly
TScan Therapeutics initiated with a Buy at BTIG
8M ago
TScan Therapeutics price target raised to $14 from $9 at Barclays
Premium
The Fly
TScan Therapeutics price target raised to $14 from $9 at Barclays
8M ago
TScan Therapeutics Advances in Solid and Hematological Cancer Therapy
PremiumCompany AnnouncementsTScan Therapeutics Advances in Solid and Hematological Cancer Therapy
9M ago
TScan Therapeutics announces $125M common stock offering
Premium
The Fly
TScan Therapeutics announces $125M common stock offering
9M ago
TScan Therapeutics appoints Chrysta Louis M.D CMO
Premium
The Fly
TScan Therapeutics appoints Chrysta Louis M.D CMO
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100